Fibroblast Growth Factor 23 (FGF-23)

• If you have persistently low blood phosphate levels that are not easily explained by diet or other medical conditions.
• When monitoring kidney function, especially in the context of chronic kidney disease progression and associated mineral and bone disorders.
• If you are experiencing symptoms such as bone pain, muscle weakness, or bone deformities that could be indicative of a phosphate imbalance.
• After diagnosis of certain rare genetic disorders affecting phosphate metabolism, to help guide treatment and monitor disease activity.
• If other related lab tests, such as calcium, vitamin D, or parathyroid hormone (PTH) levels, are abnormal.

• Individuals experiencing unexplained low phosphate levels (hypophosphatemia) or high phosphate levels (hyperphosphatemia).
• Those with known or suspected chronic kidney disease, as FGF-23 levels can be elevated in kidney dysfunction and relate to mineral bone disorder.
• Patients being evaluated for genetic disorders of phosphate metabolism, such as X-linked hypophosphatemia or tumor-induced osteomalacia.
• People with bone disorders or symptoms like bone pain, muscle weakness, or fractures, where phosphate imbalances might be a contributing factor.

The Fibroblast Growth Factor 23 (FGF-23) test is a vital diagnostic tool commonly used to investigate and manage conditions related to phosphate and bone metabolism. It is particularly valuable for:

• Diagnosis and Monitoring of Hypophosphatemia: This test helps identify the underlying causes of persistently low blood phosphate levels, including genetic disorders like X-linked hypophosphatemia (XLH) and acquired conditions such as tumor-induced osteomalacia (TIO). Elevated FGF-23 is a hallmark of these phosphate-wasting disorders.
• Assessing Chronic Kidney Disease (CKD) Progression and Mineral Bone Disorder: In individuals with CKD, FGF-23 levels often rise early in the disease course, playing a significant role in phosphate dysregulation and the development of CKD-mineral and bone disorder (CKD-MBD), including renal osteodystrophy.
• Evaluating Bone Disorders: When patients present with symptoms such as bone pain, muscle weakness, or fractures, and phosphate imbalances are suspected, FGF-23 levels can provide crucial insights into the metabolic pathways involved.
• Investigating Vitamin D Resistant Rickets/Osteomalacia: FGF-23 inhibits the kidney's ability to activate vitamin D. Therefore, elevated FGF-23 can contribute to conditions where bones soften due to inadequate vitamin D action, even with supplementation.
• Differentiating Causes of Phosphate Imbalance: In complex cases of phosphate dysregulation, alongside other markers like calcium, parathyroid hormone (PTH), and vitamin D, FGF-23 helps narrow down the diagnostic possibilities and guide appropriate therapeutic strategies.

It is important to remember that blood test results should always be interpreted by a qualified healthcare professional. FGF-23 levels need to be considered in conjunction with your medical history, symptoms, and other laboratory findings to make an accurate diagnosis and determine appropriate management. This test is a tool to provide insights and should not replace professional medical advice.